Memantine Improves Attentional Processes in Fragile X-Associated Tremor/Ataxia Syndrome: Electrophysiological Evidence from a Randomized Controlled Trial

Progressive cognitive deficits are common in patients with fragile X-associated tremor/ataxia syndrome (FXTAS), with no targeted treatment yet established. In this substudy of the first randomized controlled trial for FXTAS, we examined the effects of NMDA antagonist memantine on attention and worki...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jin-Chen, Rodriguez, Annette, Royston, Ashley, Niu, Yu-Qiong, Avar, Merve, Brill, Ryan, Simon, Christa, Grigsby, Jim, Hagerman, Randi J., Olichney, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761982/
https://www.ncbi.nlm.nih.gov/pubmed/26898832
http://dx.doi.org/10.1038/srep21719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761982/
https://www.ncbi.nlm.nih.gov/pubmed/26898832
http://dx.doi.org/10.1038/srep21719

Ejemplares similares